SCHEMBL7155233

SCHEMBL7155233

CN(C)c1cccc(C(=O)NCC2Cc3c(sc(NC4CCCCO4)c3C(=O)O)CO2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.56
KDM4E B2RXH2 3/20 0.56
HSD17B10 Q99714 2/20 0.56
ALDH1A1 P00352 2/20 0.56
TP53 P04637 2/20 0.56
POLB P06746 1/20 0.56
TSHR P16473 1/20 0.56
HPGD P15428 6/20 0.42
NPC1 O15118 3/20 0.42
KMT2A Q03164 2/20 0.42
RAB9A P51151 2/20 0.41
GFER P55789 1/20 0.41
RAB7A P51149 2/20 0.40
CYP1A2 P05177 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ATM Q13315 1/20 0.39
HTT P42858 2/20 0.38
MAPT P10636 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6321243 0.85 ALDH1A1 (0.53) SMN1; SMN2KDM4EHSD17B10ALDH1A1TP53
SCHEMBL7859642 0.83 KDM4E (0.39) SMN1; SMN2KDM4EHSD17B10ALDH1A1TP53
SCHEMBL6428209 0.83 HPGD (0.54) SMN1; SMN2KDM4EHSD17B10ALDH1A1TP53
SCHEMBL7159306 0.83 HPGD (0.52) SMN1; SMN2ALDH1A1POLBHPGDNPC1
SCHEMBL7860892 0.81 SMYD3 (0.36) SMN1; SMN2KDM4EHSD17B10ALDH1A1TP53
SCHEMBL7159868 0.81 HPGD (0.47) SMN1; SMN2KDM4EHSD17B10ALDH1A1TP53
SCHEMBL7855442 0.79 KDM4E (0.55) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL6400737 0.79 RAB7A (0.37) SMN1; SMN2HSD17B10ALDH1A1POLBTSHR
SCHEMBL7162038 0.79 MAPT (0.54) TP53POLBRAB9AMAPT
SCHEMBL7864273 0.78 HPGD (0.41) SMN1; SMN2KDM4EHSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) MOLLER NIELS PETER HUNDAHL (DK) 2003-04-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRA SMN1; SMN2 1576/4885KDM4E 2352/4885HSD17B10 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.